# Pepsi's 41% Upside Target Sparks Wall Street Debate

> BNP Paribas Exane's $183 target for PepsiCo implies 41% gains, but North American struggles threaten the bull case.
- Title: Pepsi's 41% Upside Target Sparks Wall Street Debate | Shortify
- Summary: BNP Paribas Exane's $183 target for PepsiCo implies 41% gains, but North American struggles threaten the bull case. PepsiCo's shares trade 19% below Wall…
- Keywords: pepsico, bnpparibasexane, price target, pepsi, s&p 500, dividend aristocrat, north america, international growth, tariff refunds, forward p/e, Pepsi's, Upside
- Source: 24/7 Wall St. — https://247wallst.com/investing/2026/09/21/pepsis-fall-continues-one-prominent-firms-resolute-target-implies-41-gains-moving-forward
- Author: Alex Sirois
- Published: 2026-09-21T13:55:36+00:00
- Read time: 1 min
- Topics: pepsico, bnpparibasexane, price target, pepsi, s&p 500, dividend aristocrat, north america, international growth, tariff refunds, forward p/e
## PepsiCo's Current Price
PepsiCo trades at $129.75, while Wall Street analysts average $155, leaving shares 19% below consensus.
## North American Slump
PepsiCo Foods North America revenue fell 2% in Q2, with core operating margins contracting 40 basis points.
## BNP Paribas Target
BNP Paribas Exane maintains a $183 price target, implying 41% upside from current levels.
## International Growth
Latin America Foods grew 15%, Asia Pacific Foods grew 12%, and EMEA grew 10% in Q2.
## Wall Street Split
Among 24 analysts, 4 Strong Buy, 3 Buy, 16 Hold, and 1 Sell split reflects cautious sentiment.
## Bull Case Requirements
North American volume must stabilize while international growth and tariff refunds deliver 1 point of EPS growth.
## Coca-Cola Comparison
Coca-Cola trades at $88.15 against a $94.70 target, implying 7% upside, near its 52-week high.
## Pepsi's 41% Upside
PepsiCo's $129.75 price with BNP Paribas Exane's $183 target implies 41% gains if North America stabilizes.
## Key takeaway

PepsiCo's shares trade 19% below Wall Street consensus at $155, with BNP Paribas Exane's $183 target requiring North American volume stabilization.